Lexette (halobetasol Propionate) Foam recalls
The FDA has published 1 recall involving Lexette (halobetasol Propionate) Foam since 2022. The latest was reported on 26 Jan 2022. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing1latest 26 Jan 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why lexette (halobetasol propionate) foam is recalled
Companies
By year
Ongoing lexette (halobetasol propionate) foam recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lexette (halobetasol propionate) Topical Foam, 0.05% canisters recalled | Mayne Pharma | Manufacturing (CGMP) Deviations | Nationwide |
All lexette (halobetasol propionate) foam recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lexette (halobetasol propionate) Topical Foam, 0.05% canisters recalled | Mayne Pharma | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Lexette (halobetasol Propionate) Foam?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.